Conference
THE CHA2DS2-VASC SCORE IDENTIFIES AF PATIENTS WITH A CHADS2 SCORE OF 0 OR 1 TREATED WITH ANTIPLATELET THERAPY WHO ARE UNLIKELY TO BENEFIT FROM ORAL ANTICOAGULANT THERAPY
Authors
Coppens M; Eikelboom J; Hart R; Yusuf S; Lip G; Dorian P; Shestakovska O; Connolly S
Volume
59
Publisher
Elsevier
Publication Date
March 2012
DOI
10.1016/s0735-1097(12)60571-3
Conference proceedings
Journal of the American College of Cardiology
Issue
13
ISSN
0735-1097